Search - tctmd.com

Displaying 501 - 520 of 1304

Sort: Relevancy | Date

News Daily News

El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina

L.A. McKeown

April 28, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

L.A. McKeown

April 28, 2015

Presentation

Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8

Presenter: Gregory Ducrocq

April 24, 2015

Presentation

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Presenter: K.A. Fiedler

April 22, 2015

Presentation

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

Presenter: E.J. Armstrong

April 22, 2015

Presentation

ACC 2015 Late Breaking Trials: PCI Access and Anticoagulation Trials

Presenter: Gregg W. Stone

April 14, 2015

Presentation ARCH 2015

Acute Coronary Syndromes

Presenter: Richard G. Bach

April 10, 2015

News Daily News

元分析解释了不同DAPT时间长短的影响

Caitlin E. Cox

April 03, 2015

News Daily News

Un Meta Análisis Arrojan Luz sobre el Impacto de la Duración del Tratamiento Antiplaquetario Doble

Caitlin E. Cox

April 03, 2015

News Daily News

Meta-analyses Shed Light on the Impact of DAPT Duration

Caitlin E. Cox

April 03, 2015

News Daily News

BRIGHT 发布：直接 PCI 患者长时间输注比伐卢定可减少出血并控制早期支架血栓形成

April 03, 2015

News Daily News

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

April 03, 2015

News Daily News

BRIGHT Publicado: Bivalirudina Prolongada Reduce las Hemorragias y Controla la Trombosis Precoz del Stent en PCI Primarias

April 03, 2015

Presentation

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

Presenter: D. J. Kereiakes

March 24, 2015

News Daily News

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

Yael L. Maxwell

March 24, 2015

Presentation

BRIGHT: Bivalirudin vs Heparin With or Without Tirofiban During Primary PCI in Acute MI

Presenter: Yaling Han

March 23, 2015

Presentation

Mortality in Pts Treated With Extended Duration Dual Antiplatelet Therapy (DAPT) After DES

Presenter: T. Palmerini

March 18, 2015

News Conference News ACC 2015

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Todd Neale

March 17, 2015

Presentation ACC 2015

Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Presenter: Marc S. Sabatine

March 14, 2015

News Conference News ACC 2015

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

Todd Neale

March 14, 2015

Advertisement

El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After DES Implantation

Association of DAPT With Reduced Major Adverse Cardiovascular Events in Symptomatic PAD

ACC 2015 Late Breaking Trials: PCI Access and Anticoagulation Trials

Acute Coronary Syndromes

元分析解释了不同DAPT时间长短的影响

Un Meta Análisis Arrojan Luz sobre el Impacto de la Duración del Tratamiento Antiplaquetario Doble

Meta-analyses Shed Light on the Impact of DAPT Duration

BRIGHT 发布：直接 PCI 患者长时间输注比伐卢定可减少出血并控制早期支架血栓形成

BRIGHT Published: Prolonged Bivalirudin Reduces Bleeding, Tames Early Stent Thrombosis in Primary PCI

BRIGHT Publicado: Bivalirudina Prolongada Reduce las Hemorragias y Controla la Trombosis Precoz del Stent en PCI Primarias

Antiplatelet Therapy Duration Following BMS or DES: The DAPT Randomized Clinical Trial

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

BRIGHT: Bivalirudin vs Heparin With or Without Tirofiban During Primary PCI in Acute MI

Mortality in Pts Treated With Extended Duration Dual Antiplatelet Therapy (DAPT) After DES

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content